$14.63
+0.25 (+1.74%)
Open$14.27
Previous Close$14.38
Day High$14.74
Day Low$14.27
52W High$19.11
52W Low$7.94
Volume—
Avg Volume1.21M
Market Cap1.14B
P/E Ratio—
EPS$-3.50
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
-37.0% upside
Current
$14.63
$14.63
Target
$9.21
$9.21
$6.71
$9.21 avg
$14.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.86M | 39.33M | 211.34M |
| Net Income | -265,109,767 | -261,707,568 | 52.60M |
| Profit Margin | -739.4% | -702.5% | 24.9% |
| EBITDA | -275,582,888 | -287,159,968 | 60.54M |
| Free Cash Flow | — | — | 38.74M |
| Rev Growth | -8.8% | -8.8% | -6.2% |
| Debt/Equity | — | — | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |